CIK 0001043961 · Non-accelerated filer<br>Smaller reporting company
Precipio, Inc.
Sign in to watch- Ticker
- PRPO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911789357
- Phone
- 203 787 7888
- Business address
- 4 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- TRANSGENOMIC INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −833 | 0 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +833 | 833 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −3,333 | 0 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +3,333 | 3,333 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −18,000 | 0 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −16,250 | 0 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +16,250 | 16,250 | ||
| 2024-07-15 | Valauri Christina Rizopoulos Director | Grant or award | +2,103 | $4.63 | $10K | 3,549 |
| 2024-07-15 | Cossman Jeffrey Director | Grant or award | +2,265 | $4.63 | $10K | 10.73 |
| 2024-07-15 | Cohen David Seth Director | Grant or award | +2,832 | $4.63 | $13K | 45,578 |
| 2024-07-15 | ANDREWS RONALD ASBURY Director | Grant or award | +2,157 | $4.63 | $10K | 9,618 |
| 2024-06-21 | Valauri Christina Rizopoulos Director | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2024-06-21 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2024-06-21 | Gage Matthew CFO | Grant or award · Stock Option (Right to Buy) | +4,000 | 4,000 | ||
| 2024-06-21 | SANDBERG RICHARD A Director | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2024-06-21 | Cohen David Seth Director | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2024-06-21 | DANIELI ILAN CEO | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 |
Page 10 of 11 · 211 trades